ICOS Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SemiBull who wrote (1015)	11/21/2003 12:04:50 PM
From: tuck	Read Replies (1) of 1139

>>11:21AM ICOS follow-up : Wires reporting that FDA has approved Eli Lilly's (LLY 71.37 -0.16) erectile dysfunction drug Cialis (tadalafil). Partner ICOS is set to receive 50% of the revs which are projected to be up to $1 bln. Approval was expected this month. After popping to as high as $47.08 on the news, ICOS Corp (ICOS 46.50 +1.47) shares have consolidated a portion of their intra-day gains.<< Courtesy of Briefing.com The stock seems to be selling off a bit on the news, but there is no PR yet, so we don't know what the label is. Currently at $43.30 as I type. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next